Cite
HARVARD Citation
de Anda-Jáuregui, G. et al. (2015). Crosstalk events in the estrogen signaling pathway may affect tamoxifen efficacy in breast cancer molecular subtypes. Computational biology and chemistry. pp. 42-54. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
de Anda-Jáuregui, G. et al. (2015). Crosstalk events in the estrogen signaling pathway may affect tamoxifen efficacy in breast cancer molecular subtypes. Computational biology and chemistry. pp. 42-54. [Online].